The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The goal of this funding opportunity announcement is to solicit applications that will creatively use datasets and resources from the Human BioMolecular Atlas Program (HuBMAP: to demonstrate their use to address significant biomedical and biological questions. Projects are expected to work closely with the other funded projects as part of the HuBMAP Consortium to provide specific and actionable feedback, validations, tools, software and other resources back to the consortium.

Companion FOA: RFA-RM-21-026 , U54 Specialized Center (Cooperative Agreements)


  • Letters of Intent Receipt Date(s): Oct. 19, 2021
  • Application Due Date(s): Nov. 19, 2021

RFA-RM-21-027 Expiration Date: November 20, 2021

Agency Website

Areas of Interest




Amount Description

Application budgets are limited to $300,000 in direct costs (excluding subcontract F&A) per year and need to reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is 4 years.

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 19, 2021